PYXS 8-K 2026-10-01

Pyxis Oncology, Inc. (PYXS) 8-K dated 2026-10-01 — accession 0001437749-26-031767. This URL is the filing, not the PYXS hub.

Pyxis Oncology, Inc. (PYXS) is a biotechnology company listed on NASDAQ.

Pyxis Oncology, Inc. filed a 8-K on 2026-10-01. Accession 0001437749-26-031767.

Cached items: 1.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PYXS revenue for 2025-12-31 was $13.9M. Net income was -$79.6M. Revenue was down 14.2% from 2024-12-31 to 2025-12-31. PYXS currently screens at market cap $109.6M.

Not investment advice. The PYXS SEC hub lists recent forms. The stock page is the research view.